{"id":"W2123744385","doi":"10.1016/s0140-6736(02)08905-5","title":"Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial","year":2002,"lang":"en","type":"article","venue":"The Lancet","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":2548,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; St. Michael's Hospital; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Acarbose; Medicine; Impaired glucose tolerance; Placebo; Internal medicine; Diabetes mellitus; Flatulence; Type 2 diabetes; Clinical endpoint; Type 2 Diabetes Mellitus; Gastroenterology; Hazard ratio; Randomized controlled trial; Endocrinology; Confidence interval; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null}